Veliparib (ABT-888)
Veliparib (ABT-888, NSC 737664) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM in cell-free assays, respectively. It is inactive to SIRT2. Veliparib increases autophagy and apoptosis. Phase 3.
Supplier | Selleck Chemicals |
---|---|
Product # | S1004 |
Sku # | S1004-200mg |
Pricing | 200mg, $790.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2021Quote: ... Veliparib (Selleck Chemicals; #S1004), Talazoparib (Selleck Chemicals ...
-
Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer CellsbioRxiv - Cancer Biology 2023Quote: ... PARP1/2 inhibitor Veliparib (Selleck Chemical LLC S100410MG), 10-CL-BBQ (BBQ ...